​Vertex sales prediction for top-selling drug lower than hoped
In a highly anticipated announcement today in San Francisco, executives from Vertex Pharmaceuticals told investors they expect $1.1 billion to $1.3 billion in sales of the cystic fibrosis drug Orkambi this year, falling short of most expectations. Boston-based Vertex (Nasdaq: VRTX) made the announcement at the J.P. Morgan Healthcare Conference Sunday afternoon, one of the first of what will likely be several big announcements from local biotech companies over the next several days. The 2017 guidance… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 8, 2017 Category: Pharmaceuticals Authors: Don Seiffert Source Type: news

Lumacaftor-Ivacaftor Combination Effective for Some Cystic Fibrosis Patients Lumacaftor-Ivacaftor Combination Effective for Some Cystic Fibrosis Patients
The combination of lumacaftor and ivacaftor is effective for the long-term treatment of patients with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation, according to the PROGRESS study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 4, 2017 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Colorado biotech to streamline operations, explore alternatives after clinical trial failure
A Boulder maker of experimental cystic fibrosis drugs is cutting back and has begun exploring “strategic alternatives” a month after its lead compound disappointed in clinical trials. Nivalis Therapeutics (Nasdaq: NVLS) hired advisory firm Ladenburg Thalmann& Co. Inc. to help the Nivalis board consider alternatives, including a possible sale, acquisition or merger for the business, the company said. Nivalis also intends to streamline its operations as it focuses on “maximizing stockholder… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 4, 2017 Category: Biotechnology Authors: Greg Avery Source Type: news

Colorado biotech to streamline operations, explore alternatives after clinical trial failure
A Boulder maker of experimental cystic fibrosis drugs is cutting back and has begun exploring “strategic alternatives” a month after its lead compound disappointed in clinical trials. Nivalis Therapeutics (Nasdaq: NVLS) hired advisory firm Ladenburg Thalmann& Co. Inc. to help the Nivalis board consider alternatives, including a possible sale, acquisition or merger for the business, the company said. Nivalis also intends to streamline its operations as it focuses on “maximizing stockholder… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 4, 2017 Category: Pharmaceuticals Authors: Greg Avery Source Type: news

A Surprising Lower Airway Infection A Surprising Lower Airway Infection
What lessons can be learned from the surprising cause of a lower airway infection in a child with cystic fibrosis?Thorax (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - January 2, 2017 Category: Radiology Tags: Pulmonary Medicine Journal Article Source Type: news

Anthera's cystic fibrosis drug fails late-stage study, shares tank
(Reuters) - Anthera Pharmaceuticals Inc said on Tuesday that its drug to treat certain cystic fibrosis patients failed a late-stage study, sending the company's shares tumbling nearly 70 percent in after-hours trading. (Source: Reuters: Health)
Source: Reuters: Health - December 27, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Death and Taxes – The Certainty of Life
Yet in the medical and pharmaceutical world, this continual pounding was offset by my personal encounters with some outstanding people – whose deaths, or the work they did with the dying, taught me about how much more we can do to facilitate a better end of life for patients. After all, even when drugs cease to be useful, physical and emotional needs still persist.It ’s about the little thingsAn English geriatrician and campaigner for better patient care,Kate Granger, founded the‘Hello my name is…’ campaign in the UK. Designed to encourage doctors to introduce themselves to patients as a prio...
Source: EyeForPharma - December 22, 2016 Category: Pharmaceuticals Authors: Emma D ' arcy Source Type: news

Bacterial'Sabotage' Drives Cystic Fibrosis Inflammation (CME/CE)
(MedPage Today) -- Inhibiting Cif enzyme could be novel treatment for CF (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - December 18, 2016 Category: Infectious Diseases Source Type: news

Cochrane Priority Reviews List: Update
February 2017 UpdateThe February 2017 revision of the Cochrane Priority Reviews List includes new titles from the Cochrane Acute Respiratory Infections, Cystic Fibrosis& Genetic Disorders, ENT, Musculoskeletal, and Wounds Groups.The following titles on the list are open to new authors:Biomarkers for predicting outcomes in endometrial cancer (Gynaecological, Neuro-oncology and Orphan Cancer)Diagnostic test accuracy of sentinel LN node sampling in endometrial cancer (Gynaecological, Neuro-oncology and Orphan Cancer)Immunomodulatory treatment for amyotrophic lateral sclerosis /motor neuron disease (ALS/MND) (Neuromuscular...
Source: Cochrane News and Events - December 14, 2016 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

Bacterial'sabotage' handicaps ability to resolve devastating lung inflammation in cystic fibrosis
The chronic lung inflammation that is a hallmark of cystic fibrosis, has, for the first time, been linked to a new class of bacterial enzymes that hijack the patient ’s immune response and prevent the body from calling off runaway inflammation, according to a laboratory investigation. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 13, 2016 Category: Science Source Type: news

Pitts study links cystic fibrosis lung inflammation to opportunistic bacteria
An investigation led by the University of Pittsburgh School of Medicine has found a link between a new class of bacterial enzymes and the chronic lung inflammation that plagues patients with cystic fibrosis, a terminal lung disease characterized by excess mucus buildup in the body. The study, published Monday by the Proceedings of the National Academy of Sciences, details that the bacteria, P. aeruginosa, thrives in inflamed lungs, secreting an enzyme called Cif that sabotages the body’s ability… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 12, 2016 Category: Pharmaceuticals Authors: Lydia Nuzum Source Type: news

Pitts study links cystic fibrosis lung inflammation to opportunistic bacteria
An investigation led by the University of Pittsburgh School of Medicine has found a link between a new class of bacterial enzymes and the chronic lung inflammation that plagues patients with cystic fibrosis, a terminal lung disease characterized by excess mucus buildup in the body. The study, published Monday by the Proceedings of the National Academy of Sciences, details that the bacteria, P. aeruginosa, thrives in inflamed lungs, secreting an enzyme called Cif that sabotages the body’s ability… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 12, 2016 Category: Biotechnology Authors: Lydia Nuzum Source Type: news

Bacterial 'sabotage' handicaps ability to resolve devastating lung inflammation
(University of Pittsburgh Schools of the Health Sciences) The chronic lung inflammation that is a hallmark of cystic fibrosis, has, for the first time, been linked to a new class of bacterial enzymes that hijack the patient's immune response and prevent the body from calling off runaway inflammation, according to a laboratory investigation led by the University of Pittsburgh School of Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 12, 2016 Category: Infectious Diseases Source Type: news

MRSA Eradication Feasible in Cystic Fibrosis Patients MRSA Eradication Feasible in Cystic Fibrosis Patients
Methicillin-resistant Staphylococcus aureus (MRSA) eradication can be completed with few treatment-related side effects in children and adults with cystic fibrosis (CF), according to results from a randomized controlled trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 9, 2016 Category: Consumer Health News Tags: Public Health & Prevention News Source Type: news

Protein disrupts infectious biofilms
Researchers have discovered a protein that inhibits biofilms of a bacterium responsible for many cystic fibrosis infections. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 8, 2016 Category: Science Source Type: news

Protein disrupts infectious biofilms
(California Institute of Technology) Researchers discover a protein that inhibits biofilms of a bacterium responsible for many cystic fibrosis infections. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 8, 2016 Category: Global & Universal Source Type: news

This Specific Type Of Exercise Improves Men's Fertility
If you’re a man who spends a little more time on the couch than you want to admit, and you’re planning to start trying for a baby soon, here’s some advice: Exercise could significantly improve the quality of your sperm.  Specifically, moderate steady state cardio like jogging could improve your sperm’s speed, shape and volume, according to a new study published in the journal Reproduction.  How different exercises affected the quality of men’s sperm  A six-month study among 261 previously sedentary men in Iran found that those who were randomly assigned to start exercising on a ...
Source: Science - The Huffington Post - December 7, 2016 Category: Science Source Type: news

This Specific Type Of Exercise Improves Men's Fertility
If you’re a man who spends a little more time on the couch than you want to admit, and you’re planning to start trying for a baby soon, here’s some advice: Exercise could significantly improve the quality of your sperm.  Specifically, moderate steady state cardio like jogging could improve your sperm’s speed, shape and volume, according to a new study published in the journal Reproduction.  How different exercises affected the quality of men’s sperm  A six-month study among 261 previously sedentary men in Iran found that those who were randomly assigned to start exercising on a ...
Source: Healthy Living - The Huffington Post - December 7, 2016 Category: Consumer Health News Source Type: news

Person of the Year 2016 Runner-Up: The CRISPR Pioneers
[time-ad size=”large”] Table of ContentsPerson of the Year THE CHOICE DONALD TRUMP The Short List HILLARY CLINTON THE HACKERS RECEP TAYYIP ERDOGAN THE CRISPR PIONEERS BEYONCÉ Plus EUROPE’S POPULIST REVOLT ARE PRESIDENTS ALWAYS POY? 90 YEARS OF POY BY ALICE PARK Dr. Carl June’s lab at the University of Pennsylvania looks like any other biology research hub. There are tidy rows of black-topped workbenches flanked by shelves bearing boxes of pipettes and test tubes. There’s ad hoc signage marking the different workstations. And there are postdocs buzzing around, calibra...
Source: TIME.com: Top Science and Health Stories - December 5, 2016 Category: Consumer Health News Authors: Alice Park Tags: person of the year POY Source Type: news

First structural map of cystic fibrosis protein sheds light on how mutations cause disease
Scientists have created the first three-dimensional map of the protein responsible for cystic fibrosis, an inherited disease for which there is no cure. This achievement offers the kinds of insights essential to better understanding and treating this often-fatal disease, which clogs the lungs with sticky mucus, leading to breathing problems or respiratory infections. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 1, 2016 Category: Science Source Type: news

First structural map of the cystic fibrosis protein sheds light on how mutations cause disease
A map that shows the arrangement of atoms within the cystic fibrosis protein will help researchers better understand how specific mutations cause disease. Ultimately, this knowledge may reveal potential targets for new drugs. More » (Source: The Rockefeller University Newswire)
Source: The Rockefeller University Newswire - December 1, 2016 Category: Biomedical Science Authors: Wynne Perry Tags: Science News CFTR cryo-electron microscopy cystic fibrosis Jue Chen structural and chemical biology Zhe Zhan Source Type: news

First structural map of cystic fibrosis protein sheds light on how mutations cause disease
(Rockefeller University) A map that shows the arrangement of atoms within the cystic fibrosis protein will help researchers better understand how specific mutations cause disease. Ultimately, this knowledge may reveal potential targets for new drugs. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 1, 2016 Category: Biology Source Type: news

Multidrug-Resistant Mycobacteria Found in CF Patients Worldwide Multidrug-Resistant Mycobacteria Found in CF Patients Worldwide
A new, extra-virulent strain of a nontuberculous mycobacterium (NTM) that infects cystic fibrosis (CF) patients has rapidly found its way around the world, new findings show.Reuters Health Information (Source: Medscape PublicHealth Headlines)
Source: Medscape PublicHealth Headlines - November 29, 2016 Category: Primary Care Tags: Pulmonary Medicine News Source Type: news

A Betraying Breath : Living In The Uncertainty Of A Chronic Illness
All it takes is but a single breath for life to become so very real. In a single breath the heaviness of life and its fragility can pour into the depths of the soul. In a single breath lives a reality that is unchangeable, unfair, and heartbreaking. Within a single breath lives my very truth from which I so often times am on a quest to outrun. A truth that every breath I am given does not come without cost or heartache. A truth that is blended amidst quiet embers of fear waiting to ignite into a consuming blaze - waiting silently to steal that very breath and this life I love. Betrayal in a Single Breath Without conscious...
Source: Healthy Living - The Huffington Post - November 23, 2016 Category: Consumer Health News Source Type: news

An Unusual case of Burkholderia dolosa Infection in a Cystic Fibrosis Patient but Not His Sister
Irreversible decline in lung function is one of the key contributors to mortality and morbidity in the cystic fibrosis (CF) population [1]. One key determinant of lung health is recurrent respiratory infections with opportunistic pathogens. Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans, Haemophilus influenzae, non-tuberculous mycobacteria, Staphylococcus aureus, Aspergillus fumigatus, and Burkholderia cepacia complex (BCC) are common opportunistic agents of infections or chronic pulmonary colonizers in the CF population [1]. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - November 19, 2016 Category: Microbiology Authors: Grace Y. Lam, Josette Salgado, Jamil Kanji, James E.A. Zlosnik, Neil E. Brown, Winnie M. Leung Tags: Case Report Source Type: news

[In Depth] Study suggests hidden epidemic in CF patients
Between 5% and 10% of cystic fibrosis (CF) patients become infected with Mycobacterium abscessus, a pathogen that thrives in the excess of thick mucus amassing in the airways of CF patients. Some of them die as a result. Until recently, scientists believed that patients picked up the microbe at random, from the soil or water. But an analysis of hundreds of bacterial genomes from patients around the world, published in this week's issue of Science, suggests that the bacterium has adapted to humans and that several dangerous strains are spreading from one CF treatment center to the next, from country to country, and even bet...
Source: ScienceNOW - November 10, 2016 Category: Science Authors: Kai Kupferschmidt Tags: Infectious Disease Source Type: news

[Report] Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
Lung infections with Mycobacterium abscessus, a species of multidrug-resistant nontuberculous mycobacteria, are emerging as an important global threat to individuals with cystic fibrosis (CF), in whom M. abscessus accelerates inflammatory lung damage, leading to increased morbidity and mortality. Previously, M. abscessus was thought to be independently acquired by susceptible individuals from the environment. However, using whole-genome analysis of a global collection of clinical isolates, we show that the majority of M. abscessus infections are acquired through transmission, potentially via fomites and aerosols, of recent...
Source: ScienceNOW - November 10, 2016 Category: Science Authors: Josephine M. Bryant Source Type: news

A Superbug That Threatens People With Cystic Fibrosis Is Spreading Globally
In this study, researchers from Cambridge and the Wellcome Trust Sanger Institute sequenced the genomes of more than 1,000 samples of mycobacteria from 517 CF patients at specialist clinics in Europe, the United States and Australia. They found that the majority of patients had picked up transmissible forms of M. abscessus that had spread globally. Further analysis suggested the infection may be transmitted within hospitals via contaminated surfaces and through the air, the researchers said - presenting a serious challenge to infection control practices in hospitals. Because the superbug has already become resistant to man...
Source: Healthy Living - The Huffington Post - November 10, 2016 Category: Consumer Health News Source Type: news

A Superbug That Threatens People With Cystic Fibrosis Is Spreading Globally
In this study, researchers from Cambridge and the Wellcome Trust Sanger Institute sequenced the genomes of more than 1,000 samples of mycobacteria from 517 CF patients at specialist clinics in Europe, the United States and Australia. They found that the majority of patients had picked up transmissible forms of M. abscessus that had spread globally. Further analysis suggested the infection may be transmitted within hospitals via contaminated surfaces and through the air, the researchers said - presenting a serious challenge to infection control practices in hospitals. Because the superbug has already become resistant to man...
Source: Science - The Huffington Post - November 10, 2016 Category: Science Source Type: news

Multi-drug resistant infection spreading globally among cystic fibrosis patients
A multi-drug resistant infection that can cause life-threatening illness in people with cystic fibrosis (CF) and can spread from patient to patient has spread globally and is becoming increasingly virulent, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 10, 2016 Category: Science Source Type: news

Multi-drug resistant infection spreading globally among cystic fibrosis patients
(University of Cambridge) A multi-drug resistant infection that can cause life-threatening illness in people with cystic fibrosis and can spread from patient to patient has spread globally and is becoming increasingly virulent, according to new research published today in the journal Science. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 10, 2016 Category: Infectious Diseases Source Type: news

Pole dancer has just 'months to live' after her body has rejected her second transplant
Kirstie Tancock, 27, from Honiton, Devon, has suffered from cystic fibrosis since she was born. But in a blog, she says she has suffered her second organ rejection and is now too ill to receive a third. (Source: the Mail online | Health)
Source: the Mail online | Health - November 8, 2016 Category: Consumer Health News Source Type: news

To Your Health: NLM update: Cystic fibrosis research institute's potential
Listen to the To Your Health: NLM update on Cystic fibrosis research institute's potential. The transcript is also available. The Cystic Fibrosis Foundation just opened its own research institute to speed the development of medications in a move that will be watched by other disease advocacy organizations, finds a recent article published in Science... (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - November 7, 2016 Category: Consumer Health News Source Type: news

Assessing the Airway Microbiota in Cystic Fibrosis
Cystic fibrosis (CF) lung disease is characterized by chronic airway bacterial infections and airway inflammation. Microbiologic cultures of CF airway samples identify a narrow spectrum of pathogenic bacteria. More recently, culture-independent techniques have identified much more diverse microbial communities within the CF airways. The role of these bacterial communities in CF disease progression and pulmonary exacerbations is under investigation. This review discusses advances in molecular approaches for microbiota analysis; challenges in airway sampling; recent findings in airway microbiota in CF, including longitudinal...
Source: Clinical Microbiology Newsletter - November 4, 2016 Category: Microbiology Authors: Jordana E. Hoppe, J. Kirk Harris, Edith T. Zemanick Source Type: news

Fluorescent sensor provides low-cost diagnosis of cystic fibrosis
Scientists have developed a new diagnostic test for cystic fibrosis. The new device provides a cheaper, easier way to detect levels of chloride in sweat, which are elevated in cystic fibrosis patients. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 2, 2016 Category: Science Source Type: news

A lead to overcome resistance to antibiotics
Pseudomonas aeruginosa is a common bacterium in the environment. It can however become a formidable pathogen causing fatal infections, especially in intubated patients, people suffering from cystic fibrosis or severe burns. The presence of certain metals in the natural or human environment of the bacterium makes it more dangerous and, in particular, resistant to antibiotics of last resort. A team of researchers has shown that a specific protein of P. aeruginosa, called Host factor q (Hfq), is essential for reacting to these metals and acquire these new properties. The results single out the Hfq protein as the Achilles heel...
Source: ScienceDaily Headlines - October 5, 2016 Category: Science Source Type: news

Nurse Assist Initiates Nationwide Voluntary Recall of All Unexpired Lots of I.V. Flush Syringes
Nurse Assist, Inc. announced today that it is voluntarily recalling all unexpired lots of I.V. Flush Syringes due to a potential link to Burkholderia cepacia bloodstream infections with the product.  According to the U.S. Centers for Disease Control and Prevention (CDC), the effects of Burkholderia cepacia on people'vary widely, ranging from no symptoms at all to serious respiratory infections, especially in patients with cystic fibrosis.' If a patient is having symptoms, contact your health care provider. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 5, 2016 Category: Food Science Source Type: news

Curing inherited disease by running a stop sign
(University of Alabama at Birmingham) A study published today by scientists at University of Massachusetts Medical School and the University of Alabama at Birmingham provides insight into the mechanism of action of the drug ataluren, which is showing promise in treating Duchenne muscular dystrophy and cystic fibrosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 4, 2016 Category: Global & Universal Source Type: news

FDA OKs Cystic Fibrosis Drug Orkambi for Younger Patients FDA OKs Cystic Fibrosis Drug Orkambi for Younger Patients
The lumacaftor/ivacaftor combination drug is now approved for children aged 6 to 11 years with two copies of the F508del mutation in the CTFR gene.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 29, 2016 Category: Drugs & Pharmacology Tags: Pulmonary Medicine News Alert Source Type: news

Cystic Fibrosis: Ensuring adequate nutrition
People with cystic fibrosis (CF) need help to ensure they are getting correct nutrition and the right amount of enzymes. They also need constant reminders. Researchers are now developing a digital support device to promote autonomy, but are finding that this is no easy task. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 28, 2016 Category: Science Source Type: news

FDA Approves Orkambi (lumacaftor/ivacaftor) for Use in Children with Cystic Fibrosis Ages 6 through 11 who have Two Copies of the F508del Mutation
BOSTON--(BUSINESS WIRE) September 28, 2016 -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) approved Orkambi (lumacaftor/ivacaftor) for use in children with cystic fibrosis (CF)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 28, 2016 Category: Drugs & Pharmacology Source Type: news

Katie Prager dies days after her husband
Katie Prager, the wife in the real "Fault in Our Stars" couple, died Thursday after complications from cystic fibrosis and a lung transplant. She was 26 years old. (Source: CNN.com - Health)
Source: CNN.com - Health - September 23, 2016 Category: Consumer Health News Source Type: news

Katie Prager, wife in real 'Fault in Our Stars' couple, dies
Katie Prager, the wife in the real "Fault in Our Stars" couple, died Thursday after complications from cystic fibrosis and a lung transplant. She was 26 years old. (Source: CNN.com - Health)
Source: CNN.com - Health - September 23, 2016 Category: Consumer Health News Source Type: news

Real-life Fault in Our Stars wife with cystic fibrosis dies
Katie Prager and her husband Dalton Prager met on Facebook in 2009. Dalton Prager died Saturday at a St. Louis hospital from cystic fibrosis, which clogs the lungs with mucus. (Source: the Mail online | Health)
Source: the Mail online | Health - September 23, 2016 Category: Consumer Health News Source Type: news

Real 'Fault in Our Stars' couple: Katie Prager dies
Katie Prager, the wife in the real "Fault in Our Stars" couple, died Thursday after complications from cystic fibrosis and a lung transplant. She was 26 years old. (Source: CNN.com - Health)
Source: CNN.com - Health - September 22, 2016 Category: Consumer Health News Source Type: news

'Fault in our Stars' wife dies 5 days after husband
Katie Prager died after complications from cystic fibrosis and a lung transplant. She was 26 years old. (Source: CNN.com - Health)
Source: CNN.com - Health - September 22, 2016 Category: Consumer Health News Source Type: news

A real 'Fault in Our Stars' couple
Katie and Dalton Prager both had cystic fibrosis. Despite doctors' warnings, they married and became known as the real "Fault in Our Stars" couple. They passed away days apart from each other in September 2016. (Source: CNN.com - Health)
Source: CNN.com - Health - September 22, 2016 Category: Consumer Health News Source Type: news

Dalton and Katie Prager: A love story
Katie and Dalton Prager both had cystic fibrosis. Despite doctors' warnings, they married and became known as the real "Fault in Our Stars" couple. They passed away days apart from each other in September 2016. (Source: CNN.com - Health)
Source: CNN.com - Health - September 22, 2016 Category: Consumer Health News Source Type: news

A low-cost sensor for cystic fibrosis diagnosis
A new, inexpensive method for detecting salt concentrations in sweat or other bodily fluids has been developed by biomaterials scientists. The fluorescent sensor, derived from citric acid molecules, is highly sensitive and highly selective for chloride, the key diagnostic marker in cystic fibrosis. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 20, 2016 Category: Science Source Type: news

Gene therapy for cystic fibrosis lung disease
Gene therapy may be a viable approach for treating or preventing lung disease caused by cystic fibrosis (CF), suggests new research. Working with CF pigs, the researchers have shown that two different virus-based vectors can restore a working version of the cystic fibrosis transmembrane conductance regulator (CFTR) protein that is faulty in CF to the pigs'airway cells. Moreover, this gene replacement normalized important aspects of the lung biology and improved the ability of airway secretions to kill bacteria. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 20, 2016 Category: Science Source Type: news